rofecoxib has been researched along with Aura in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with rofecoxib selectively and significantly (P < 0." | 1.31 | The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. ( Kunz, T; Oliw, EH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunz, T | 1 |
| Oliw, EH | 1 |
1 other study available for rofecoxib and Aura
| Article | Year |
|---|---|
The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus.
Topics: Animals; Cell Death; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epile | 2001 |